Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from MSD

‘Patients will suffer’: tales from the frontline of the UK pharma crisis

The pricing standoff between government and industry has stalled research and put thousands of jobs at risk

The Guardian - UK

NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump

UK ministers preparing to raise payments to end standoff with pharma industry, cited as reason for firms axing British investments

The Guardian - UK

UK set on resolving standoff with big pharma, science minister says

Patrick Vallance says relations must improve and NHS has to reverse decline in drugs investment

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

UK ‘difficult’ operating environment says Merck boss after £1bn London site axed

Last week, Merck’s business in the UK and Europe, MSD, said it will move its life sciences operation to the US, impacting around 125 British jobs.

Evening Standard

Big pharma firms have paused nearly £2bn in UK investments this year

Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears

The Guardian - UK

Merck’s move to axe £1bn UK expansion was ‘commercial decision’, says minister

The Conservatives said Merck’s decision should send alarm bells ringing across Government.

Evening Standard

Pharma giant ditches £1bn London research hub and says UK ‘is not internationally competitive’

Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most attractive place to invest in the world’

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

US drugmaker Merck scraps £1bn London research centre and cuts 125 science jobs

New blow to UK’s key life science sector as industry body says country is losing ground on investment and research

The Guardian - UK

‘Touch and go’: Reading stuck in brinkmanship battle over sale as deadline looms

Reading are trapped in a three-way battle of brinkmanship involving owner Dai Yongge and two potential buyers, leaving staff at the club fearing they will be forced into administration next month.

The Guardian - UK

Proposed sale of Reading to Robert Platek faces conflict of interest concerns

A company for which Robert Platek works has lent money to other EFL clubs, leading one executive at another club to remark: ‘At best it doesn’t look good’

The Guardian - UK

One of science’s greatest achievements: how the rapid development of COVID vaccines prepares us for future pandemics

Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 million deaths from the disease. This makes COVID the seventh-deadliest pandemic in recorded history.

The Conversation

Your gas stove might be making your asthma worse. Here’s what you can do about it

We may think of air pollution as an outdoor problem, made up of car exhaust and smog. But if the air inside our homes is polluted, this can also affect our health.

The Conversation

New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots

COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.

The Conversation

Boston Celtics retain multiple companies to assist in franchise’s sale

The Boston Celtics have retained the world-leading companies to assist in the sale of the franchise.

USA Today Sports Media Group

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Healthcare Stocks Benefiting From an Aging Population

The healthcare industry is set for growth due to the growing demand for quality healthcare services and the aging population. Hence, quality healthcare stocks, such as Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK), might be worth looking into. Read more….

StockNews.com

3 Pharmaceutical Stocks With Strong Pipelines

The pharmaceutical industry is flourishing due to increasing medical demands and rising healthcare spending worldwide. Hence, pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck & Co. (MRK), with strong pipelines, might be worth buying. Read more….

The Times of India

IPL: Leg-muscle tear forcing MS Dhoni to bat down the order

Movements are severely restricted but team's injury issues not allowing legend to take a break

The Times of India

IPL 2024: How MS Dhoni is using the 'Impact Player' rule

NEW DELHI: The 'Impact Player' rule, according to Michael Hussey, the batting coach for the Chennai Super Kings, has extended their batting order, enabling former captain Mahendra Singh Dhoni to bat as late as number eight in this IPL.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Times of India

6th trophy loading!: MS Dhoni's colossal sixes during CSK net session are 'pure goosebumps'. Watch

NEW DELHI: Gearing up for the upcoming season of the Indian Premier League, Chennai Super Kings' MS Dhoni was seen launching the balls into orbit during the team's training session at the Chepauk.

The Times of India

MS Dhoni's final IPL season? AB de Villiers gives a major update on the legend

NEW DELHI: As MS Dhoni gears up for another IPL season with the Chennai Super Kings (CSK), speculation looms over whether this might be his final campaign in the league. Having led CSK to their fifth title triumph in the previous season, Dhoni's leadership and experience remain invaluable assets for…

The Times of India

'This diesel engine never...': AB de Villiers on talismanic CSK captain MS Dhoni

NEW DELHI: Former South African cricketer AB de Villiers has likened Chennai Super Kings (CSK) skipper MS Dhoni to a diesel engine that never stops working.

Dynamite News

Researchers identify potential treatment target for genetic type of epilepsy

A team of researchers discovered a possible target for treating a hereditary form of epilepsy. Read further on Dynamite News:

Newsroom.co.nz

Wage subsidy gets pass mark for engaging Māori – in inexplicable change

Ministry of Social Development bosses pushed back against original performance score in wage subsidy scheme assessment, reports David Williams

Newsroom.co.nz

Verdict on $19b wage subsidy lands, a year late

Newsroom.co.nz

Christchurch terror attacks board ‘a waste of time’

A board set up to help victims of the Christchurch mosque shootings is a 'joke', a former member says.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.